Loading organizations...
Spruce Ventures operates as a venture capital firm, providing early-stage capital to developing companies. The firm identifies promising ventures and deploys financial resources to support their growth. Its investment strategy includes the publishing sector, directly participating in market opportunities to assist innovative businesses through critical funding stages.
Established in 2018, Spruce Ventures is headquartered in New York, New York. The founders' identities and the specific insights driving its creation are not publicly detailed. Its formation reflects a commitment to backing new companies with strategic financial support and guidance.
Spruce Ventures targets early-stage companies requiring capital to scale operations. The firm's vision centers on cultivating a successful portfolio, driving industry evolution, and delivering value for stakeholders. It actively seeks ventures poised for significant future impact and growth.
Spruce Ventures has 1 tracked investment across 1 company. The latest tracked deal is $40.0M Series C in Evolve Biosystems in June 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2018 | Evolve Biosystems | $40.0M Series C | Bill & Melinda Gates Foundation, Horizons Ventures | Acre Venture Partners, Alta Ventures, Arla Foods, BOW Capital, Continental Grain Company, Johnson & Johnson Innovation, Tate & Lyle Ventures |